Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer
Current Pharmaceutical Biotechnology (2015) - Comments
doi: 10.2174/138920101606150407114407  issn: 1389-2010  pubmed: 25860066  issn: 1873-4316 

Florencia Zalazar, Paola Luca, Kevin Gardner, William D Figg, Roberto Meiss, Raul G Spallanzani, Pablo Vallecorsa, Belen Elguero, Javier Cotignola, Elba Vazquez, Adriana Siervi